About Notable Labs
Notable Labs is a precision oncology company focused on improving cancer treatment outcomes through functional precision medicine. The company uses artificial intelligence and machine learning to analyze how individual patient tumor cells respond to various cancer therapies in laboratory settings before treatment begins. By testing patient-derived tumor samples against multiple drug combinations ex vivo, Notable Labs aims to identify the most effective treatment options for each patient, moving beyond traditional genomic profiling approaches. The company's platform combines high-throughput drug screening with AI-powered predictive analytics to generate personalized treatment recommendations. This approach is designed to reduce trial-and-error in cancer treatment selection, potentially improving patient outcomes while reducing exposure to ineffective therapies. Notable Labs serves oncologists and cancer patients by providing actionable insights that inform treatment decisions in hematologic malignancies and solid tumors.
Clinical Focus
Medical conditions and clinical areas addressed by Notable Labs.
Who It Serves
Social & Media
Follow on
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.